National Healthcare Properties, Inc. 8-K

What Happened

• National Healthcare Properties, Inc. (NHP) filed an 8-K on May 15, 2026 reporting the results of its 2026 Annual Meeting. Stockholders holding 14,327,574 shares (about 50.42% of outstanding common stock) were present in person or by proxy.
• All six nominees were re-elected as directors: Michael Anderson; Leslie D. Michelson; Scott W. Humphrey; Elizabeth K. Tuppeny; B.J. Penn; and Edward M. Weil, Jr. PricewaterhouseCoopers LLP (PwC) was ratified as NHP’s independent registered public accounting firm for the year ending December 31, 2026. Stockholders also approved the non‑binding advisory resolution on executive compensation and voted to hold that advisory vote annually.

Key Details

• Shares represented at meeting: 14,327,574 (≈50.42% of 28,412,183 outstanding).
• Director election vote tallies (For / Withhold / Broker non‑votes):
  • Michael Anderson: 4,891,027 / 715,955 / 8,720,592
  • Leslie D. Michelson: 4,764,872 / 842,110 / 8,720,592
  • Scott W. Humphrey: 4,919,345 / 687,637 / 8,720,592
  • Elizabeth K. Tuppeny: 4,769,358 / 837,624 / 8,720,592
  • B.J. Penn: 4,748,257 / 858,725 / 8,720,592
  • Edward M. Weil, Jr.: 4,832,620 / 774,362 / 8,720,592
• Auditor ratification (Proposal 2): For 13,649,192; Against 332,687; Abstain 345,695.
• Say‑on‑pay (Proposal 3, non‑binding): For 4,153,701; Against 1,011,880; Abstain 441,401; Broker non‑votes 8,720,592.
• Frequency vote (Proposal 4): One year 4,588,573; Two years 130,935; Three years 206,195; Abstain 681,279. Board will hold annual advisory votes on executive compensation through at least the next required frequency vote (no later than 2032).

Why It Matters

• Governance continuity: Re-election of all incumbent directors signals board stability and continued strategic oversight without changes to board composition.
• Auditor continuity: Ratification of PwC maintains consistency in NHP’s external audit relationship for 2026, relevant to financial reporting oversight.
• Shareholder oversight on pay: The non‑binding “say‑on‑pay” was approved and stockholders chose an annual frequency, meaning investors can expect yearly advisory votes on executive compensation going forward (these votes are advisory, not binding).